Tower Research Capital LLC (Trc) Verona Pharma PLC Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Verona Pharma PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 960 shares of VRNA stock, worth $34,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

960

Previous 1,166 17.67%

Holding current value

$34,233

Previous $16,000 68.75%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.46 - $30.16 $3,184 - $6,212	-206 Reduced 17.67%	960 $27,000
Q2 2024 Aug 13, 2024	BUY	$11.48 - $17.02 $5,349 - $7,931	466 Added 66.57%	1,166 $16,000
Q1 2024 May 15, 2024	SELL	$15.3 - $20.24 $58,063 - $76,810	-3,795 Reduced 84.43%	700 $11,000
Q4 2023 Feb 13, 2024	BUY	$11.94 - $20.47 $48,559 - $83,251	4,067 Added 950.23%	4,495 $89,000
Q3 2023 Nov 14, 2023	SELL	$16.3 - $22.09 $44,173 - $59,863	-2,710 Reduced 86.36%	428 $6,000
Q2 2023 Aug 14, 2023	SELL	$19.41 - $23.43 $27,096 - $32,708	-1,396 Reduced 30.79%	3,138 $66,000
Q1 2023 May 09, 2023	BUY	$18.06 - $25.27 $68,682 - $96,101	3,803 Added 520.25%	4,534 $91,000
Q4 2022 Feb 10, 2023	BUY	$9.84 - $26.13 $1,751 - $4,651	178 Added 32.19%	731 $19,000
Q3 2022 Nov 10, 2022	SELL	$4.14 - $13.59 $6,512 - $21,377	-1,573 Reduced 73.99%	553 $6,000
Q2 2022 Aug 15, 2022	BUY	$3.55 - $5.06 $3,887 - $5,540	1,095 Added 106.21%	2,126 $8,000
Q1 2022 May 12, 2022	BUY	$4.82 - $6.98 $3,364 - $4,872	698 Added 209.61%	1,031 $5,000
Q4 2021 Feb 14, 2022	SELL	$3.91 - $7.08 $5,646 - $10,223	-1,444 Reduced 81.26%	333 $2,000
Q3 2021 Nov 15, 2021	BUY	$5.29 - $6.35 $2,179 - $2,616	412 Added 30.18%	1,777 $10,000
Q2 2021 Aug 16, 2021	BUY	$5.72 - $9.09 $7,807 - $12,407	1,365 New	1,365 $9,000
Q3 2020 Nov 16, 2020	SELL	$4.45 - $10.2 $890 - $2,039	-200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.6 - $6.12 $720 - $1,224	200 New	200 $1,000
Q3 2019 Nov 05, 2019	SELL	$4.03 - $5.44 $1,055 - $1,425	-262 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$5.1 - $6.91 $530 - $718	-104 Reduced 28.42%	262 $1,000
Q1 2019 May 14, 2019	SELL	$5.52 - $10.0 $419 - $760	-76 Reduced 17.19%	366 $2,000
Q4 2018 Feb 14, 2019	BUY	$9.0 - $13.47 $1,683 - $2,518	187 Added 73.33%	442 $4,000
Q2 2018 Aug 15, 2018	SELL	$13.66 - $21.0 $2,936 - $4,515	-215 Reduced 45.74%	255 $3,000
Q1 2018 May 15, 2018	BUY	$11.69 - $20.97 $5,494 - $9,855	470 New	470 $9,000
Q4 2017 Feb 09, 2018	SELL	$10.8 - $15.75 $2,149 - $3,134	-199 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.96 - $16.95 $2,380 - $3,373	199	199 $3,000

Others Institutions Holding VRNA

# of Institutions

166

Shares Held

68.7M

Call Options Held

704K

Put Options Held

685K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.17B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Verona Pharma PLC Transaction History